See analyst estimates and all valuation multiples for Chemicals
Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
---|---|---|---|
$243B | 7.3x | 18.5x | |
$101B | 4.3x | 22.0x | |
$84.4B | 5.3x | 22.8x | |
$79.5B | 6.6x | 15.8x | |
$69.3B | 0.9x | 7.5x | |
$54.4B | 26.1x | 1452.1x | |
$50.0B | 3.3x | 17.1x | |
$49.8B | 2.8x | 7.2x | |
$45.1B | 1.2x | 8.7x | |
$42.9B | 1.6x | 7.6x | |
$37.4B | 1.4x | 8.2x | |
$36.8B | 0.9x | 7.9x | |
$35.9B | 2.9x | 11.1x | |
$35.0B | 7.4x | 19.9x | |
$32.4B | 1.0x | 8.9x | |
$30.8B | 2.0x | 11.6x | |
$28.9B | 2.6x | 13.5x | |
$26.8B | 6.7x | 37.3x | |
$25.8B | 2.1x | 12.9x | |
$23.4B | 4.0x | 10.0x | |
$21.3B | 2.3x | 10.3x | |
$21.1B | 3.6x | 10.7x | |
$19.0B | 0.5x | 2.3x | |
$18.8B | 1.9x | 8.6x | |
$18.2B | 4.3x | 16.0x | |
$17.9B | 3.0x | 14.3x | |
$17.9B | 6.9x | 23.7x | |
$17.1B | 2.8x | 7.2x | |
$16.9B | 1.3x | 9.6x | |
$16.7B | 2.3x | 14.6x | |
$16.6B | 3.2x | 11.4x | |
$16.5B | 1.0x | 13.4x | |
$13.8B | 1.5x | 7.8x | |
$13.8B | 0.8x | 5.7x | |
$13.6B | 1.1x | 7.1x | |
$13.3B | 0.9x | 5.7x | |
$13.0B | 2.9x | 8.7x | |
$12.4B | 2.4x | 11.9x | |
$10.9B | 4.9x | 11.4x | |
$10.9B | 3.6x | 9.7x | |
$10.4B | 1.5x | 6.0x | |
$10.2B | 1.3x | 6.3x | |
$9.7B | 0.5x | 5.6x | |
$9.4B | 1.7x | 13.6x | |
$9.2B | 2.2x | 10.3x | |
$9.1B | 0.8x | 5.2x | |
$8.1B | 0.6x | 3.1x | |
$7.0B | 7.3x | 27.1x | |
$6.4B | 1.5x | 10.0x | |
$6.3B | 2.9x | 8.6x | |
$5.8B | 1.0x | 4.8x | |
$5.8B | 1.1x | 9.7x | |
$5.5B | 2.8x | 11.0x | |
$5.5B | 0.7x | 7.7x | |
$5.4B | 6.7x | 23.1x | |
$5.4B | 1.0x | 6.3x | |
$5.3B | 0.6x | 6.8x | |
$5.2B | 12.0x | 38.3x | |
$4.6B | 0.7x | 5.3x | |
$4.6B | 1.8x | 13.5x | |
$4.5B | 0.4x | 12.9x | |
$4.2B | n/a | n/a | |
$3.9B | 1.1x | 5.8x | |
$3.7B | 1.7x | 8.3x | |
$3.7B | n/a | n/a | |
$3.6B | 0.9x | 15.8x | |
$3.4B | 12.6x | 54.6x | |
$3.2B | 5.2x | 29.5x | |
$3.0B | 0.9x | -125.1x | |
$2.6B | 0.6x | 3.7x | |
$2.5B | n/a | n/a | |
$2.4B | 0.8x | 6.3x | |
$2.2B | 2.9x | 11.1x | |
$2.1B | 2.1x | 11.3x | |
$2.1B | 0.7x | 6.1x | |
$1.8B | 0.2x | 5.1x | |
$1.8B | 7.0x | 21.4x | |
$1.7B | 1.5x | 11.4x | |
$1.6B | 2.5x | 12.7x | |
$1.5B | 1.5x | 8.6x | |
$1.5B | 2.1x | 8.8x | |
$1.4B | n/a | n/a | |
$1.4B | 2.6x | n/a | |
$1.2B | 1.2x | 11.9x | |
$1.1B | 0.6x | 27.3x | |
$1.0B | 0.7x | 7.2x | |
$758M | n/a | n/a | |
$728M | n/a | n/a | |
$632M | 0.2x | 36.8x | |
$623M | 1.3x | 6.4x | |
$615M | 0.5x | 3.7x | |
$604M | 1.0x | 7.2x | |
$554M | n/a | n/a | |
$541M | 0.4x | 5.8x | |
$535M | 1.4x | 10.2x | |
$471M | 0.8x | 5.3x | |
$463M | 8.9x | 29.4x | |
$445M | 1.8x | 11.4x | |
$444M | 5.4x | -13.5x | |
$433M | 0.6x | 5.7x | |
$404M | 0.7x | 5.3x | |
$403M | 0.8x | 2.7x | |
$357M | 1.5x | 8.6x | |
$349M | 0.2x | 3.2x | |
$314M | n/a | n/a | |
$292M | n/a | n/a | |
$289M | 7.3x | -7.0x | |
$289M | 0.5x | 7.2x | |
$267M | n/a | n/a | |
$253M | n/a | n/a | |
$222M | n/a | n/a | |
$205M | n/a | n/a | |
$199M | 11.4x | -6.7x | |
$179M | 0.4x | 4.4x | |
$170M | 147.3x | -536.9x | |
$153M | 0.6x | 3.8x | |
$138M | 1.2x | 6.3x | |
$129M | n/a | n/a | |
$124M | 5.9x | -6.1x | |
$115M | 5.5x | 16.5x | |
$109M | n/a | n/a | |
$101M | n/a | n/a | |
$91.4M | n/a | n/a | |
$80.0M | 38.4x | -2.2x | |
$78.2M | n/a | n/a | |
$77.4M | 0.8x | 4.2x | |
$74.9M | 0.6x | 8.7x | |
$74.3M | 356.8x | -12.0x | |
$64.5M | n/a | n/a | |
$48.0M | 0.5x | 4.5x | |
$45.5M | n/a | n/a | |
$45.2M | 12.5x | -6.8x | |
$44.1M | 0.5x | 10.7x | |
$43.8M | 2.5x | 15.4x | |
$43.1M | 0.8x | 17.7x | |
$37.2M | 1.7x | 30.1x | |
$36.1M | 0.5x | 41.7x | |
$34.9M | n/a | n/a | |
$28.5M | 2.1x | 35.9x | |
$26.8M | n/a | n/a | |
$24.3M | n/a | n/a | |
$21.5M | 2.0x | -9.9x | |
$21.0M | n/a | n/a | |
$20.8M | n/a | n/a | |
$18.3M | n/a | n/a | |
$17.5M | n/a | n/a | |
$16.9M | n/a | n/a | |
$16.6M | n/a | n/a | |
$16.2M | 1.6x | -5.2x | |
$15.8M | n/a | n/a | |
$12.0M | n/a | n/a | |
$11.3M | 1.8x | 344.0x | |
$11.1M | n/a | n/a | |
$8.6M | n/a | n/a | |
$8.2M | 54.4x | -2.3x | |
$6.7M | 127.6x | -8.6x | |
$6.2M | n/a | n/a | |
$5.5M | n/a | n/a | |
$5.3M | n/a | n/a | |
$5.1M | n/a | n/a | |
$4.7M | n/a | n/a | |
$4.3M | n/a | n/a | |
$3.5M | n/a | n/a | |
$3.3M | n/a | n/a | |
$2.8M | n/a | n/a | |
$2.7M | 7.6x | -0.2x | |
$2.7M | n/a | n/a | |
$2.1M | n/a | n/a | |
$1.7M | n/a | n/a | |
$1.6M | n/a | n/a | |
$1.1M | n/a | n/a | |
$0.9M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Chemicals